Filing Details

Accession Number:
0001209191-21-008638
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-08 20:25:26
Reporting Period:
2021-02-04
Accepted Time:
2021-02-08 20:25:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1340652 Chemocentryx Inc. CCXI Pharmaceutical Preparations (2834) 943254365
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1733642 San Pui Kwan C/O Chemocentryx, Inc.
850 Maude Avenue
Mountain View CA 94043
Principal Acctg Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-04 1,389 $10.86 4,621 No 4 M Direct
Common Stock Acquisiton 2021-02-04 1,125 $11.02 5,746 No 4 M Direct
Common Stock Acquisiton 2021-02-04 833 $9.04 6,579 No 4 M Direct
Common Stock Disposition 2021-02-04 3,347 $65.00 3,232 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-02-04 1,389 $0.00 1,389 $10.86
Common Stock Stock Option (right to buy) Disposition 2021-02-04 1,125 $0.00 1,125 $11.02
Common Stock Stock Option (right to buy) Disposition 2021-02-04 833 $0.00 833 $9.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,286 2028-03-05 No 4 M Direct
25,875 2029-03-04 No 4 M Direct
26,667 2029-11-01 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. As of February 4, 2021, and prior to this transaction, the exercised options were fully vested.
  3. Not applicable.